Study Evaluating The Safety And Tolerability Of ILV-094 In Subjects With Psoriasis
Clinical trial NCT00563524 · COMPLETED
Trial details
- NCT number
- NCT00563524
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-20
- Primary completion
- 2010-06-14
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.